Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)
(NASDAQ: ACRV) Delayed: 2.07 -0.02 (0.96%)
Previous Close $2.09    52 Week High
Open $2.07    52 Week Low
Day High $2.13    P/E N/A 
Day Low $2.03    EPS
Volume 356,518